Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

481 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Patient-reported health-related quality of life from a randomized phase II trial comparing standard-dose with high-dose twice daily thoracic radiotherapy in limited stage small-cell lung cancer.
Killingberg KT, Halvorsen TO, Fløtten Ø, Brustugun OT, Langer SW, Nyman J, Hornslien K, Madebo T, Schytte T, Risum S, Tsakonas G, Engleson J, Grønberg BH. Killingberg KT, et al. Among authors: nyman j. Lung Cancer. 2022 Apr;166:49-57. doi: 10.1016/j.lungcan.2022.02.002. Epub 2022 Feb 8. Lung Cancer. 2022. PMID: 35183991 Free article. Clinical Trial.
Stereotactic body radiotherapy for medically inoperable patients with stage I non-small cell lung cancer - a first report of toxicity related to COPD/CVD in a non-randomized prospective phase II study.
Baumann P, Nyman J, Hoyer M, Gagliardi G, Lax I, Wennberg B, Drugge N, Ekberg L, Friesland S, Johansson KA, Lund JS, Morhed E, Nilsson K, Levin N, Paludan M, Sederholm C, Traberg A, Wittgren L, Lewensohn R. Baumann P, et al. Among authors: nyman j. Radiother Oncol. 2008 Sep;88(3):359-67. doi: 10.1016/j.radonc.2008.07.019. Epub 2008 Sep 1. Radiother Oncol. 2008. PMID: 18768228 Clinical Trial.
Outcome in a prospective phase II trial of medically inoperable stage I non-small-cell lung cancer patients treated with stereotactic body radiotherapy.
Baumann P, Nyman J, Hoyer M, Wennberg B, Gagliardi G, Lax I, Drugge N, Ekberg L, Friesland S, Johansson KA, Lund JA, Morhed E, Nilsson K, Levin N, Paludan M, Sederholm C, Traberg A, Wittgren L, Lewensohn R. Baumann P, et al. Among authors: nyman j. J Clin Oncol. 2009 Jul 10;27(20):3290-6. doi: 10.1200/JCO.2008.21.5681. Epub 2009 May 4. J Clin Oncol. 2009. PMID: 19414667 Clinical Trial.
Concurrent cetuximab and radiotherapy after docetaxel-cisplatin induction chemotherapy in stage III NSCLC: satellite--a phase II study from the Swedish Lung Cancer Study Group.
Hallqvist A, Wagenius G, Rylander H, Brodin O, Holmberg E, Lödén B, Ewers SB, Bergström S, Wichardt-Johansson G, Nilsson K, Ekberg L, Sederholm C, Nyman J. Hallqvist A, et al. Among authors: nyman j. Lung Cancer. 2011 Feb;71(2):166-72. doi: 10.1016/j.lungcan.2010.05.011. Epub 2010 Jun 11. Lung Cancer. 2011. PMID: 20541833 Clinical Trial.
Swedish lung cancer radiation study group: predictive value of histology for radiotherapy response in patients with non-small cell lung cancer.
Holgersson G, Bergström S, Bergqvist M, Nyman J, Hoye E, Helsing M, Friesland S, Holgersson M, Birath E, Ekman S, Blystad T, Ewers SB, Mörth C, Löden B, Henriksson R. Holgersson G, et al. Among authors: nyman j. Eur J Cancer. 2011 Nov;47(16):2415-21. doi: 10.1016/j.ejca.2011.06.011. Epub 2011 Jul 2. Eur J Cancer. 2011. PMID: 21726999
The value of induction chemotherapy for survival in patients with non-small cell lung cancer treated with radiotherapy.
Holgersson G, Sandelin M, Hoye E, Bergström S, Henriksson R, Ekman S, Nyman J, Helsing M, Friesland S, Brodin O, Holgersson M, Lundström KL, Janson C, Ekberg L, Mörth C, Blystad T, Ewers SB, Löden B, Bergqvist M. Holgersson G, et al. Among authors: nyman j. Anticancer Res. 2012 Apr;32(4):1339-46. Anticancer Res. 2012. PMID: 22493368
481 results